ClinicalTrials.gg
CompletedNCT05743478FHFUpdated Sep 3, 2026

Forging Hopeful Futures to Reduce Youth Violence

An interventional study of Forging Hopeful Futures and Wellness Check-ins in Violence in Adolescence, Racism and Adolescent Behavior, sponsored by University of Pittsburgh. Completed at 2 sites in United States. Open to participants aged 13 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
542
Allocation
Randomized
Ages
13 Years to 19 Years
Sex
All
01

Study summary

This cluster-randomized community-partnered study will examine the effectiveness of a racial-, gender-, and economic-justice focused youth violence prevention program called Forging Hopeful Futures with youth ages 13-19.

Read the detailed description

This community-partnered cluster randomized trial in 16 neighborhoods impacted by structural inequities and high levels of community violence in Pittsburgh, PA and urban Washington D.C. and Maryland metro areas will evaluate effectiveness of Forging Hopeful Futures with youth ages 13-19. Forging Hopeful Futures combines economic justice content from job readiness training, racial and gender justice content from gender-transformative programming, and leadership building as a novel multi-level violence prevention intervention.

02

Conditions studied

  • Violence in Adolescence
  • Racism
  • Adolescent Behavior
  • Coping Skills
  • Communication, Social
  • Communication, Personal
  • Violence, Sexual
  • Violence, Non-accidental
  • Violence, Physical
  • Violence, Gender-Based
03

In context

Racism

47 studies on the registry are indexed under Racism; 8 are open to participants now.

This study's enrollment of 542 is above the median of 106 across 34 interventional studies indexed under Racism.

Browse Racism studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,419 studies on the registry; 168 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Participants must be ages 13-19 (inclusive)
  2. Participants must speak English
  3. Participants must live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
  4. Participants must be able to provide follow up contact information

Exclusion criteria

Exclusion Criteria:

  1. Not ages 13 -19 (inclusive)
  2. Do not speak English
  3. Do not live in the participating neighborhoods, attend schools in the participating neighborhoods, or use participating facilities
  4. Unable to provide follow up contact information
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
542 participants (actual)

Study arms

  • Experimental
    Forging Hopeful Futures

    Forging Hopeful Futures uses a group discussion format with activities that explore race, gender, class, identity, relationships, and multiple forms of violence. Forging Hopeful Futures is a 12 session curriculum for youth ages 13-19 that uses strengths-based and healing-centered approaches to critically examine structural forces that perpetuate racial and gender injustice, develop leadership skills in promoting gender equitable relationship norms, non-violent practices, and upstander skills, and enhance economic justice through job skills and employment opportunities. Through 12 sessions (3 hours/session) over a 6 to 12 week period, Forging Hopeful Futures combines racial, gender, and economic justice content with leadership development and workforce development opportunities.

    Behavioral: Forging Hopeful Futures

  • Active comparator
    Wellness Check-ins

    Youth in neighborhoods randomized to the control group will receive individual wellness checks. This will occur through a strengths-based telephone conversation focused on wellness resources. Youth will be provided with tailored resources based on needs identified during the call. Youth will be offered the option for additional phone check-ins to coordinate access to community resources and connection to individualized behavioral health supports if desired.

    Behavioral: Wellness Check-ins

Interventions

  • BehavioralForging Hopeful Futures

    Forging Hopeful Futures is a 12 session curriculum for youth ages 13-19 that uses strengths-based and healing-centered approaches to critically examine structural forces that perpetuate racial and gender injustice, develop leadership skills in promoting gender equitable relationship norms, non-violent practices, and upstander skills, and enhance economic justice through job skills and employment opportunities. Through 12 sessions (3 hours/session) over a 6 to 12 week period, Forging Hopeful Futures combines racial, gender, and economic justice content with leadership development and workforce development opportunities.

  • BehavioralWellness Check-ins

    Individual wellness checks will occur through a strengths-based telephone conversation focused on wellness resources. Youth will be provided with tailored resources based on needs identified during the call. Youth will be offered the option for additional phone check-ins to coordinate access to community resources and connection to individualized behavioral health supports if desired.

06

What researchers measure

Primary outcomes

  1. Change in recent violence perpetration at 3 months

    The primary outcome will be past 3-month youth violence perpetration. This will be measured by self-report on 3 items adapted from the Youth Risk Behavior Surveillance Survey, using a past-3 month reporting interval: 1) physical fighting ("How many times were you in a physical fight?"), 2) threatening someone with a weapon ("How many times have you threatened someone with a weapon such as a gun, knife, or club?"), and 3) injuring someone with a weapon ("How many times have you injured someone with a weapon such as a gun, knife, or club?"). Each item will be assessed with 8 frequency response categories from 0 times to 12 or more times. A summary score will capture the past 3-month incidence of all 3 behaviors (possible range: 0- 21;lower score indicates better outcome)

    Time frame: At baseline and three months after program conclusion

Secondary outcomes

  1. Change in recent violence perpetration at 6 months

    This will be measured using the same 3 items outlined in the primary outcome, but assessed as a change from baseline to 6 months after program conclusion. This includes self-report on 3 items adapted from the Youth Risk Behavior Surveillance Survey, using a past-3 month reporting interval: 1) physical fighting ("How many times were you in a physical fight?"), 2) threatening someone with a weapon ("How many times have you threatened someone with a weapon such as a gun, knife, or club?"), and 3) injuring someone with a weapon ("How many times have you injured someone with a weapon such as a gun, knife, or club?"). Each item will be assessed with 8 frequency response categories from 0 times to 12 or more times. A summary score will capture the past 3-month incidence of all 3 behaviors (possible range: 0- 21;lower score indicates better outcome)

    Time frame: At baseline and six months after program conclusion

  2. Change in relationship abuse at 3 months

    10 abusive behavior items, modified from Conflict Tactics Scale-2, assess for perpetration against dating partners or towards peers. Summary score of any recent use of violence in the past 3 months (physical, sexual and emotional relationship abuse) calculated as one point for each behavior then summed (possible range: 0-10; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  3. Change in sexual violence perpetration at 3 months

    4 sexual violence perpetration items assess recent sexual violence perpetration (any/none). Summary score of any recent sexual violence perpetration in the past 3 months, calculated as one point for each behavior then summed (possible range: 0-4; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  4. Change in cyber dating abuse and peer abuse

    8 items assess using technology to perpetrate abuse against a dating partner or peers. Summary score of any recent use of technology to perpetrate abuse against a dating partner or peers in the past 3 months, calculated as one point for each behavior then summed (possible range: 0-8; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  5. Change in bullying perpetration

    6 items to indicate frequency of bullying perpetration on 4-point frequency scale. Mean score of any recent bullying perpetration in the past 3 months, calculated as a mean score across the 6 items (possible range: 0-3; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  6. Change in cyberbullying perpetration

    4-item scale adapted from a cyberbullying perpetration scale, assessing perpetration frequency on a 4-point frequency scale. Mean score of recent cyberbullying perpetration in the past 3 months, calculated as a mean across the 4 items (possible range:0-3; lower score indicated better outcome).

    Time frame: At baseline and three months after program conclusion

  7. Change in weapon carrying

    1 item adapted from the Youth Risk Behavior Surveillance Survey asking about frequency of carrying a weapon in the past 30 days (measured on a 5-point frequency scale from 0 days to 6 or more days; possible range: 0-4; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  8. Change in homophobic teasing

    5-item scale with participants reporting how often they have perpetrated listed behaviors in the past 3 months (each item measured on a 6-point frequency scale from 0 times to 7 or more times). Mean score of recent homophobic teasing, calculated as a mean across the 5 items (possible range: 0-5; lower score indicates better outcome).

    Time frame: At baseline and three months after program conclusion

  9. Change in sexual harassment

    5 items assess frequency of perpetrating sexual harassing behaviors in the past 3 months, assessing perpetration frequency on a 5-point frequency scale. Mean score of recent sexual harassment perpetration in the past 3 months, calculated as a mean across the 5 items (possible range:0-4; lower score indicated better outcome).

    Time frame: At baseline and three months after program conclusion

07

Study locations

2 sites
  • Population Council
    Washington D.C., District of Columbia 20008, United States
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Publications

  • Culyba AJ, Pulerwitz J, Ajith A, Barrett S, Blankenship K, Chin A, Hanner CD, Henry C, Klotz S, Koranteng-Yorke N, Minter K, Mixson R, Mumin D, Sabia A, Sierra E, Saur N, Wilson T, Gottert A. Forging Hopeful Futures Community-Partnered Violence Prevention Intervention: Protocol for a Comparative Effectiveness Trial. JMIR Res Protoc. 2026 Apr 29;15:e90689. doi: 10.2196/90689. PubMed 42054701 ↗

Individual participant data

Plan to share: Yes — IDP data will be made available only to selected researchers who apply for access. The application must document a legitimate public health use or research question for the data, and the applicant must sign a pledge to keep all data private and to make no attempt to identify individual subjects. Access can be requested for all of the individual participant data collected during the trial, after deidentification. We will use data standards that ensure all released data have appropriate documentation that describes the method of collection, what the data represent, and potential limitations for use. Along with restricted use of the IDP, we will make available a comprehensive data dictionary that details all data elements included in the dataset, and sources of validated instruments. This use of the data is consistent with the planned language of the voluntary consent for participation agreed and in accordance with IRB policy.

Time frame: We will adhere to data sharing timelines, including sharing data (restricted use) within 30 months after the end of data collection.

Access criteria: We will make the data available only to selected researchers who apply for access. The application must document a legitimate public health use or research question for the data, and the applicant must sign a pledge to keep all data private and to make no attempt to identify individual subjects. This use of the data is consistent with the planned language of the voluntary consent for participation agreed and in accordance with IRB policy.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Aug 2026, 36 months.

Of 29 non-industry interventional studies with no phase under Racism, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 41. This study's 36 months is above that.

Counting every sponsor, half of 29 studies reached it within 32 months; a quarter within 14 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2023
First posted
Feb 24, 2023
StartActual
Jul 10, 2023
Primary completionActual
Aug 2, 2026
CompletionActual
Aug 2, 2026
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05743478
Collaborators
Population Council, Centers for Disease Control and Prevention
Responsible party
Alison Culyba (Assistant Professor of Pediatrics, University of Pittsburgh) — Principal investigator
First posted
Feb 24, 2023
Start date
Jul 10, 2023
Primary completion
Aug 2, 2026
Completion
Aug 2, 2026
Last update
Sep 3, 2026

Study contacts

Alison Culyba, MD PhD MPH
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion